CardioPharma
Manufacturing · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Bregnevej 39, Gentofte, Capital Region, ...Phone Number
(910) 791-1361Website
www.cardio-pharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About CardioPharma
CardioPharma, Inc. specializes in the global development of combinatorial cardiovascular products designed to reduce the morbidity and mortality associated with cardiovascular disease. The company addresses the significant issue of pharmaceutical non-compliance among cardiovascular patients, aiming to improve medication adherence through its innovative products. Their pipeline focuses on creating solutions that enhance convenience, reduce costs, and improve compliance for patients, healthcare providers, pharmacists, and payers worldwide. By tackling the challenges of cardiovascular disease, CardioPharma seeks to mitigate both the human and financial impacts of this global health crisis.Explore more
CardioPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CardioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at CardioPharma
Funding: Get notified immidiatlly once CardioPharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if CardioPharma had a recent Job posting/layoffs
Check out if CardioPharma is spiking on competitors!
Product Launch: Get notified when CardioPharma launches new products
Website visits: Recent activity has been detected on your website
CardioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on CardioPharma recently announced quarterly report
Check if CardioPharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at CardioPharma
Find 2 more new buyers
Compare Similar Companies to CardioPharma
Compare insights from companies similar to CardioPharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CardioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CardioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CardioPharma.
CardioPharma Tech Stack
A closer look at the technologies used by CardioPharma
CardioPharma News & Media
CardioPharma Requests Applications to Investigate the Non-Cardiovascular Benefits of CVD Polypills
WILMINGTON, N.C., Dec. 18, 2025 /PRNewswire/ -- CardioPharma, Inc. (the "Company"), a specialty pharmaceutical company focused on combinatorial drug development for cardiovascular diseases, is seeking applications for secondary analyses of existing datasets to investigate...CardioPharma Announces Issuance of Global Patent to Mitigate the World's Top Killer
WILMINGTON, N.C., May 14, 2024 /PRNewswire/ -- CardioPharma Inc. (the "Company"), a specialty pharmaceutical company focused on drug development for cardiovascular diseases, announced that on August 29, 2023, the United States Patent and Trademark Office ("USPTO") issued US Patent...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding CardioPharma
Sign Up For FreeTo access detailed company insights
CardioPharma, Inc. specializes in the global development of combinatorial cardiovascular products designed to reduce the morbidity and mortality associated with cardiovascular disease. The company addresses the significant issue of pharmaceutical non-compliance among cardiovascular patients, aiming to improve medication adherence through its innova... Read More
